Molecular pathology and clinicopathologic features of penile tumors: With special reference to analyses of p21 and p53 expression and unusual histologic features

Archives of Pathology and Laboratory Medicine

Volumn 123, Issue 10, 1999, Pages 895-904

  Lam, King Y ^a,b   Chan, Kwok W ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P21; PROTEIN P53;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; BOWEN DISEASE; CANCER DIAGNOSIS; CLINICAL EXAMINATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; PAPILLOMA; PATHOLOGY; PENIS CANCER; PROTEIN EXPRESSION; SPINDLE CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; VERRUCOUS CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; CARCINOMA, TRANSITIONAL CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM STAGING; PENILE NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032860973     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science. 1991;253:49-53.
2. El-Deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell. 1993;75:817-825.
3. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D. Induction of VVAF1/CIP1 by a p53-independent pathway. Cancer Res. 1994;54:3391-3395.
4. CP1 in muscle and other terminally differentiating cells. Science. 1995;267:1024-1026.
5. Burgers JK, Badalament RA, Drago JR. Penile cancer: clinical presentation, diagnosis, and staging. Urol Clin North Am. 1992;19:247-256.